Most automakers’ Q2 sales in the U.S. didn’t fare well, and of the three that did experience gains, one stood out ...

Key Points Ford reported a 14.2% jump in Q2 unit sales, driven by pricing incentives to lure in customers. Shares of the ...

Ford is outperforming the S&P 500 with strong Q1 results, solid cash flow, and bullish technicals, despite tariff risks. Find ...

What implications does this carry for Ford and investors? The consequences are serious. Quality issues could damage consumer ...

Following employee pricing is another incentive push. If you follow Ford Motor Company (NYSE: F), or perhaps the auto ...

The inside story of how a CEO and a group of marketers made a last-minute change of plans that now has the Ford brand leading ...

Discover Abbott Laboratories' Q2 2025 highlights: resilience drives high single-digit growth, double-digit EPS, and pipeline innovations.

Live Updates Live Coverage Updates appear automatically as they are published. Still no earnings at 7:05 a.m. ET 7:04 am by ...

The GMC Hummer EV outperformed Tesla's Cybertruck in the second quarter of 2025, with sales figures revealing a significant drop in Cybertruck purchases.

Detailed price information for Ford Motor Company (F-N) from The Globe and Mail including charting and trades.

Healthcare product and device company Abbott Laboratories (NYSE:ABT) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 7.4% year on year to $11.14 billion. Its non-GAAP profit of $1.

Abbott (NYSE: ABT) shares dipped before hours today on second-quarter results that came in ahead of the consensus forecast.